Pneumonia remains a common illness and a major cause of morbidity and morta
lity in the United States. Although a number of factors affect patient outc
ome in pneumonia, the rapid institution of effective antimicrobial therapy
is known to reduce mortality. Unfortunately, the past decade has witnessed
a dramatic increase in the prevalence of antimicrobial resistance in respir
atory pathogens and much of this resistance is related to commonly used ant
imicrobial agents. This article discusses the incidence of resistance, iden
tifies the risk factors associated with resistance, and describes the curre
nt mechanisms of resistance for bacteria that commonly cause pneumonia.